Updates are available Correction dated 2025-06-04
Click to view Correction: https://doi.org/10.1007/s12126-025-09609-9
-
Authors
Hussein, Areej https://orcid.org/0000-0003-4855-0856
Moullin, Joanna https://orcid.org/0000-0002-4103-7569
Stafford, Andrew https://orcid.org/0000-0002-6461-6846
Hughes, Jeffery https://orcid.org/0000-0003-0040-4753
Quested, Eleanor https://orcid.org/0000-0002-6211-9045
-
Funding
Funding for this research was provided by:
Curtin University
- License Information
-
More Information
Article History
Accepted: 9 September 2024
First Online: 30 October 2024
Change Date: 4 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12126-025-09609-9
Declarations
:
: This study was approved by the Curtin University Human Research Ethics Committee (Reference Number: HRE2019-0384). Prior to each focus group, written consent was obtained from each participant. Consent for a phone interview was obtained via phone and then in person.
: Two authors have conflicts of interest to declare. Professor Jeffrey Hughes is one of the co-inventors of PainChek®, the Chief Scientific Officer of PainChek Ltd (formerly known as EPAT Technologies Ltd), and a shareholder in the company. Dr Andrew Stafford is also a shareholder in the company. Positive results from the study will further support the use of PainChek® and hence could potentially benefit Professor Hughes and Dr Stafford through their shareholdings. The other authors have no conflicts of interest to declare.
: None.
: No experimental treatment was conducted on either human or animal subjects in this study.
